SOFIA (Bulgaria), December 6 (SeeNews) – Intensified trading in the shares of Bulgarian drug maker Sopharma [BUL:3JR] this week is related to the intentions of a big shareholder to reduce or sell its stake, Dimitar Georgiev, head of trading at ELANA Trading brokerage, said on Wednesday.
The bigger free-float will lead to increased liquidity of the stock, Georgiev told SeeNews in an e-mailed statement.
You can subscribe to our M&A newsletter here
Over 6 million Sopharma shares changed hands on the Bulgarian Stock Exchange on Tuesday in a total of 158 transactions at a weighted average price of 4.27 levs apiece ($2.59/2.18 euro). The volume of Sopharma shares traded represents a 4.45% stake in the company.
By 16:00 CET on Wednesday some 4.7 million Sopharma shares have changed hands in 157 transactions at a weighted average price of 4.27 levs per share.
(1 euro = 1.95583 levs)